The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry.

Therefore, it is expected that the increased availability of low input DNA sampling methods would speed up the use of next-generation sequence across various clinical and research applications.

Read More: https://www.emergenresearch.co....m/industry-report/ne